Inventor
IAN FOLTZ
Inventor
CA
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides24%
C12NMicroorganisms or enzymes12%
B82YSpecific uses or applications of nanostructures4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
Y02ATechnologies for adaptation to climate change4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
PatentTitleYear
11,965,029ST2 antigen binding proteins202411,541,103Interleukin-21 mutein/ anti-PD-1 antibody conjugates202311,518,809Targeted binding agents against B7-H1202211,518,808Anti-PD-1 antibodies and methods of treatment202211,492,411Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof202211,186,636Anti-human TREM2 antibodies and uses thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to AMGEN INC (4)· patent assignee history
2021–2024Based in CA· patent location history
2022Patents assigned to AMGEN FREMONT INC (1)· patent assignee history
2022Patents assigned to MEDIMMUNE LTD (1)· patent assignee history
2022–2023Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 4 | 2021–2024 |
| AMGEN FREMONT INC | 1 | 2022 |
| MEDIMMUNE LTD | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| CA | 4 | 2021–2024 |
| US | 2 | 2022–2023 |